Session: 572 APS Bone Cell Physiology and Signaling Poster Session
(572.2) Role of the Phosphate Transport Facilitator XPR1 in Bone Homeostasis and Phosphate-Dependent FGF23 Secretion
Sunday, April 3, 2022
10:15 AM – 12:15 PM
Location: Exhibit/Poster Hall A-B - Pennsylvania Convention Center
Poster Board Number: E266
Daniela Cabuzu (University of Lausanne), Suresh Ramakrishnan (University of Lausanne), Olivier Bonny (University of Lausanne, CHUV, Lausanne University Hospital)
Presenting Author University of Lausanne Renens, Vaud, Switzerland
Background: Evidence point at Xenotropic and Polytropic retrovirus Receptor 1 (XPR1) as a protein involved in the cellular phosphate export pathway and phosphate homeostasis: systemic constitutive deletion of Xpr1 in mice is lethal and kidney-specific deletion of Xpr1 induces hypophosphatemic rickets with hypercalciuria. XPR1 is expressed in the bone, but its function remains elusive. We hypothesized that XPR1 is crucial for bone homeostasis and that is involved in the sensing mechanism of phosphate in the bone.
Methods: We established an inducible whole body Xpr1 KO mouse model. The mice were placed in metabolic cages for urine and blood analysis, followed by femur uCT and histomorphometry. The Fgf23 mRNA and protein (c-terminal and intact FGF23) levels were assessed from tibia and femur incubated ex vivo for 24h with increasing phosphate concentrations. Primary osteoblast cells were isolated from control and Xpr1 KO mouse calvaria.
Results: Conditional total body Xpr1 KO mice are constantly decreasing their body weight upon Xpr1 deletion, and develop profound hypophosphatemia, compared to their control littermates. Histomorphometry analysis and uCT on femurs of Xpr1 KO mice show high trabecular bone density, despite low bone formation rate and low number of osteoclasts. Increased intact FGF23 secretion by tibia and femur was observed in control mice in response to increased phosphate concentration in the media. However, the bone samples from Xpr1 KO mice are resistant to phosphate induced FGF23 secretion. No changes were observed for the c-terminal FGF23 in response to increased phosphate concentration, for both the control and Xpr1 KO mice.
Osteoblasts were successfully prepared from control and Xpr1 KO mouse calvarie and Xpr1 expression was inactivated by tamoxifen treatment.
Conclusion: XPR1 is essential for phosphate homeostasis and FGF23 secretion upon phosphate exposure. Osteoblasts will now be used to further study phosphate dependent FGF23 secretion.
